Published by Josh White on 5th May 2023
(Sharecast News) - Biotechnology developer Sareum Holdings announced on Friday that it has been granted approval by Australia's Therapeutic Goods Administration (TGA) to conduct phase one clinical studies on SDC-1801.
URL: http://www.digitallook.com/dl/news/story/33485012/...